ST2 as checkpoint target for colorectal cancer immunotherapy

Immune checkpoint blockade immunotherapy delivers promising clinical results in colorectal cancer (CRC). However, only a fraction of cancer patients develop durable responses. The tumor microenvironment (TME) negatively impacts tumor immunity and subsequently clinical outcomes. Therefore, there is a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCI Insight
Main Authors: Van der Jeught, Kevin, Sun, Yifan, Fang, Yuanzhang, Zhou, Zhuolong, Jiang, Hua, Yu, Tao, Yang, Jinfeng, Kamocka, Malgorzata M., So, Ka Man, Li, Yujing, Eyvani, Haniyeh, Sandusky, George E., Frieden, Michael, Braun, Harald, Beyaert, Rudi, He, Xiaoming, Zhang, Xinna, Zhang, Chi, Paczesny, Sophie, Lu, Xiongbin
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7253019/
https://ncbi.nlm.nih.gov/pubmed/32376804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.136073
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados